劲方医药-B(02595.HK)建议采纳H股购股权计划及H股激励计划
Core Viewpoint - The company, Jinfang Pharmaceutical-B (02595.HK), announced the board's resolution to propose the adoption of an H-share buyback plan and an H-share incentive plan on November 24, 2025 [1] Group 1 - The board of Jinfang Pharmaceutical-B has made a decision regarding the implementation of a buyback plan for H-shares [1] - An incentive plan for H-shares has also been proposed by the company [1]